Skip to main content

Advertisement

SpringerLink
Log in

A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Moch H, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs–part A: renal, penile, and testicular tumours. Eur Urol. 2022;82:458–68.

    Article  PubMed  Google Scholar 

  2. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399–410.

    Article  PubMed  Google Scholar 

  3. Vera-Badillo FE, Templeton AJ, Duran I, Ocana A, de Gouveia P, Aneja P, et al. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis. Eur Urol. 2015;67:740–9.

    Article  PubMed  Google Scholar 

  4. Armstrong AJ, Nixon AB, Carmack A, Yang Q, Eisen T, Stadler WM, et al. Angiokines associated with targeted therapy outcomes in patients with non-clear cell renal cell carcinoma. Clin Cancer Res. 2021;27:3317–28.

    Article  CAS  PubMed  Google Scholar 

  5. Prochazkova K, Vodicka J, Fichtl J, Krakorova G, Sebek J, Rousarova M, et al. Outcomes for patients after resection of pulmonary metastases from clear cell renal cell carcinoma: 18 years of experience. Urol Int. 2019;103:297–302.

    Article  PubMed  Google Scholar 

  6. Harada K, Nozawa M, Uemura M, Tatsugami K, Osawa T, Yamana K, et al. Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan. Int J Urol. 2019;26:202–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Jie Wu and Bing-Qing Shang have contributed equally to this study.

Authors and Affiliations

  1. Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

    Jie Wu MD, Bing-Qing Shang MD, Jian-Zhong Shou MD & You-Yan Guan MD

Authors
  1. Jie Wu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bing-Qing Shang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-Zhong Shou MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. You-Yan Guan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to You-Yan Guan MD.

Ethics declarations

Disclosure

There are no conflict of interest.

Ethical Approval

The current study does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 kb)

10434_2023_13131_MOESM2_ESM.pdf

Supplementary Figure 1. Calibration plots of the nomogram for predicting 6-, 12-, and 18-month overall survival. (PDF 195 kb)

Supplementary Figure 2. Receiver operating characteristic (ROC) analysis based on the nomogram (PDF 9 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, J., Shang, BQ., Shou, JZ. et al. A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation. Ann Surg Oncol 30, 2590–2593 (2023). https://doi.org/10.1245/s10434-023-13131-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13131-0

Search

Navigation